Effect of adjunctive mobile phone-based text message reminders on treatment retention among inpatients with severe mental illnesses following discharge
Not Applicable
- Conditions
- Health Condition 1: F31- Bipolar disorderHealth Condition 2: F333- Major depressive disorder, recurrent, severe with psychotic symptomsHealth Condition 3: F323- Major depressive disorder, singleepisode, severe with psychotic featuresHealth Condition 4: F20- Schizophrenia
- Registration Number
- CTRI/2024/06/069070
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Diagnosis of Schizophrenia, Bipolar disorder,
Severe depression with psychotic symptoms
admitted to inpatient department of Psychiatry,
JIPMER,Puducherry
2. At least six months of duration of illness
Exclusion Criteria
1. Patients/Caregivers without access to mobile
phones
2. Patients/Caregivers who cannot read
Tamil/English
3. Patients with organic psychosis
4. Psychosis due to substance use
5. Refusal to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie treatment adherence improvement via text message reminders in severe mental illness?
How do text message reminders compare to standard-of-care interventions for relapse prevention in bipolar disorder and schizophrenia?
Which biomarkers correlate with response to mobile health interventions in recurrent major depressive disorder with psychotic symptoms?
What adverse events are associated with mobile phone-based adherence strategies in psychiatric inpatient populations?
Are there combination approaches integrating SMS reminders with pharmacological treatments for F323 and F333 mental health conditions?